VSM Wealth Advisory’s GSK GSK Stock Holding History

VSM Wealth Advisory’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.5K	Hold	640	–	–	0.01%	254
2026 Q1	$35.3K	Buy	+640	New	+$34.7K	0.01%	240
2025 Q4	–	Sell	-640	Closed	-$27.6K	–	469
2025 Q3	$27.6K	Hold	640	–	–	0.01%	249
2025 Q2	$24.6K	Hold	640	–	–	0.01%	287
2025 Q1	$24.8K	Hold	640	–	–	0.01%	258
2024 Q4	$21.6K	Buy	+640	New	+$23K	0.01%	266

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

VSM Wealth Advisory's GSK Position: Q2 2026 in Review

VSM Wealth Advisory held its GSK (GSK) position steady in Q2 2026 at 640 shares worth $33.5K. The position accounts for 0.01% of the portfolio, ranked #254.

VSM Wealth Advisory first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. The position peaked at $35.3K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

VSM Wealth Advisory held 640 shares of GSK worth $33.5K as of Q2 2026.
VSM Wealth Advisory left its GSK share count unchanged in Q2 2026.
GSK made up 0.01% of VSM Wealth Advisory's portfolio in Q2 2026, its #254 holding.
VSM Wealth Advisory first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
VSM Wealth Advisory's GSK position peaked at $35.3K in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on VSM Wealth Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.